Before joining NovaMedica within five years Ivan Daskal was responsible for legal support and control of compliance with the legislation in the Russian branch of Allergan where within the frameworks of the cross-functional tasks he developed and played the key role in implementing a number of significant local and regulatory acts of the company which referred to commercial and marketing activities, organized work aimed at struggle against counterfeit products circulation in the Russian market. Earlier Ivan headed legal function in the Diagnostic Department of Abbott Laboratories LLC (Russia), in Energomash JSC and Dirol Cadbury LLC.
Ivan graduated from the Yaroslav-the-Wise Novgorod State University, faculty of law.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
The first Russian device for testing TB is registered
14 January 2025
Russians spend 1.6 trillion rubles on medications in 2024
14 January 2025
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025
By clicking “Send”, you consent to the processing of your personal data. For more information, see Privacy Policy